Achieving Value in Cancer Care

Video

This video explores the value proposition in cancer care, with practical considerations for reducing costs at both the hospital and physician level while maintaining optimal care for cancer patients.

With the rising costs of targeted agents, immunotherapies, and combination treatment strategies, creating value while maintaining optimal care for cancer patients is of critical importance.

In this video, Daniel R. Gomez, MD, of MD Anderson Cancer Center, discusses the value proposition in cancer care, with practical considerations for reducing costs at both the hospital and physician level without sacrificing high levels of care to patients.

Gomez gave a presentation on this topic at the 2017 Multidisciplinary Thoracic Cancers Symposium, held March 16–18 in San Francisco.

Recent Videos
Response rates appeared to be higher with avutometinib plus defactinib vs avutometinib alone in the phase 2 RAMP 201 study.
Patients who respond to avutometinib/defactinib may be maintained on treatment for long periods of time, says Rachel N. Grisham, MD.
2 experts in this video
2 experts in this video
Related Content